We Offer Worldwide Shipping
Login Wishlist

Triglochinic acid

$538

  • Brand : BIOFRON

  • Catalogue Number : BD-D1324

  • Specification : 98%(HPLC)

  • CAS number : 31795-12-7

  • Formula : C7H8O6

  • Molecular Weight : 188.13

  • PUBCHEM ID : 57041970

  • Volume : 20MG

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BD-D1324

Analysis Method

HPLC,NMR,MS

Specification

98%(HPLC)

Storage

2-8℃

Molecular Weight

188.13

Appearance

Powder

Botanical Source

Pinellia pedatisecta Schott

Structure Type

Other Compounds

Category

Standards;Natural Pytochemical;API

SMILES

C(C=C(CC(=O)O)C(=O)O)C(=O)O

Synonyms

triglochinic acid/Triglochinisaeure/(2E)-2-Butene-1,2,4-tricarboxylic acid

IUPAC Name

but-2-ene-1,2,4-tricarboxylic acid

Applications

Triglochinic acid is a monomeric compound isolated from tubers of Pinellia pedatisecta Schott[1]

Density

1.549±0.06 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

Boiling Point

Melting Point

InChl

InChI=1S/C7H8O6/c8-5(9)2-1-4(7(12)13)3-6(10)11/h1H,2-3H2,(H,8,9)(H,10,11)(H,12,13)

InChl Key

PQFOLJLIMNNJQY-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

2933990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:31795-12-7) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

30159122

Title

Implementation of cancer treatment during pregnancy in daily practice: the important role of perinatologists

Author

Koen F. de Geus, Charlotte Maggen, Jorine de Haan, and Frederic Amant

Publish date

2018 Aug 7

PMID

24045942

Abstract

Janus kinase 3 (Jak3) is a nonreceptor tyrosine kinase expressed in both hematopoietic and nonhematopoietic cells. Previously, we characterized the functions of Jak3 in cytoskeletal remodeling, epithelial wound healing, and mucosal homeostasis. However, the role of Jak3 in mucosal differentiation and inflammatory bowel disease was not known. In this report, we characterize the role of Jak3 in mucosal differentiation, basal colonic inflammation, and predisposition toward colitis. Using the Jak3 knock-out (KO) mouse model, we show that Jak3 is expressed in colonic mucosa of mice, and the loss of mucosal expression of Jak3 resulted in reduced expression of differentiation markers for the cells of both enterocytic and secretory lineages. Jak3 KO mice showed reduced expression of colonic villin, carbonic anhydrase, secretory mucin muc2, and increased basal colonic inflammation reflected by increased levels of pro-inflammatory cytokines IL-6 and IL-17A in colon along with increased colonic myeloperoxidase activity. The inflammations in KO mice were associated with shortening of colon length, reduced cecum length, decreased crypt heights, and increased severity toward dextran sulfate sodium-induced colitis. In differentiated human colonic epithelial cells, Jak3 redistributed to basolateral surfaces and interacted with adherens junction (AJ) protein β-catenin. Jak3 expression in these cells was essential for AJ localization of β-catenin and maintenance of epithelial barrier functions. Collectively, these results demonstrate the essential role of Jak3 in the colon where it facilitated mucosal differentiation by promoting the expression of differentiation markers and enhanced colonic barrier functions through AJ localization of β-catenin.

KEYWORDS

β-Catenin, Colitis, Differentiation, Inflammatory Bowel Disease, Innate Immunity, Jak Kinase

Title

Role of Janus Kinase 3 in Mucosal Differentiation and Predisposition to Colitis* An external file that holds a picture, illustration, etc. Object name is sbox.jpg

Author

Jayshree Mishra,‡ Raj K. Verma,‡ Gianfranco Alpini,§ Fanyin Meng,§ and Narendra Kumar‡,1

Publish date

2013 Nov 1;

PMID

24252233

Abstract

Background
The objective of this study was to determine the pattern of congenital cardiac disease among children attending UNTH, Enugu, Nigeria. The nature of these abnormalities and the outcome were also considered. The exact etiology is unknown but genetic and environmental factors tend to be implicated. The difference in the pattern obtained worldwide and few studies in Nigeria could be due to genetic, environmental, socioeconomic, or ethnic origin.

Methods
A retrospective analysis of discharged cases in which a review of the cases of all children attending children outpatient clinics including cardiology clinic of the University of Nigeria Teaching Hospital (UNTH), Enugu over a five year period (January 2007-June 2012) was undertaken. All the children presenting with cardiac anomalies were included in the study and the cases were investigated using ECG, X-ray and echocardiography studies.

Results
A total of 31,795 children attended the children outpatient clinics of the hospital over the study period. Of these, seventy one (71) had cardiac diseases. The overall prevalence of cardiac disease is 0.22%. The commonest symptoms were breathlessness, failure to thrive and cyanosis. Almost all types of congenital detects were represented, the commonest being isolated ventricular septal detect (VSD), followed by tetralogy of Fallot. One of these cardiac anomalies presented with Downs’s syndrome and another with VACTERAL association.

Conclusions
The results of this study show that 0.22% per cent of children who attended UNTH in Enugu State had congenital cardiac abnormalities and the commonest forms seen were those with VSD.

KEYWORDS

Congenital cardiac disease, Prevalence, Pattern, Children, Enugu

Title

Synopsis of congenital cardiac disease among children attending University of Nigeria Teaching Hospital Ituku Ozalla, Enugu

Author

Josephat M Chinawa,corresponding author1 John C Eze,2 Ikechukwu Obi,3 Ijeoma Arodiwe,1 Fortune Ujunwa,1 Adiele K Daberechi,1 and Herbert A Obu1

Publish date

2013